nih-logo

An argument has been brewing on Capitol Hill and elsewhere that boils down to the theory that US taxpayers are fronting billions of dollars’ worth of public research that translates into early-stage products that are later sold to companies, go on to win FDA approval and then reap millions or billions in sales, although the government never sees a dime of those earnings.

nation-capital-consortium-for-pediatric-device-innovation-logo

The National Capital Consortium for Pediatric Device Innovation (NCC-PDI) announces 12 finalists that will present at the “Make Your Medical Device Pitch for Kids!” competition on April 30, 2019 at the University of Maryland, College Park. The finalists, all innovators in the orthopedic and spine sector, have a chance to win up to $50,000 in grant funding and access to the newly created NCC-PDI “Pediatric Device Innovator Accelerator Program” led by MedTech Innovator.

Bhi american gene sciphd logo

Are you excited about the work you do in the biohealth industry? How did you get to where you are? Would you like to be connected to the newest career ready talent pool?

Join us for a Happy Hour with post docs from NCI and other NIH institutes who have expressed interest in transitioning to our exciting industry! Help them learn about your work and opportunities in the field. You may find one of your best future hires in the process!

These events are being cohosted by BioHealth Innovation, American Gene Technologies and SciPhD. The events are free but registration is required.

Postdoc Industry Connections Happy Hour 

5/8 – 5-6:30 p.m. – American Gene Technologies

9640 Medical Center Dr Rockville, MD 20850

Register Now »

BHCR logo top 3 logo

Were you unable to attend the 2019 BioHealth Capital Region Forum? Are you looking to stay updated on what is happening with Companies/Organizations/Institutions in the BHCR throughout the year? Be sure to bookmark http://www.biohealthcapital.com/ in your internet browsers today to keep yourself in the loop. From a look back at the Forum Agenda to News on Companies in the Region, the BHCR website is one of your go-to pages along with http://www.biohealthinnovation.org/.

Do you have news to share in the region? Be sure to let us know by tagging on social media! @BiohealthCR on Twitter. We can also be found on Facebook and LinkedIn!

glycomimetics-logo

GlycoMimetics, Inc. (NASDAQ: GLYC) today announced the publication of a paper in Nature Cell Biology that describes how tumor cells engage specific stromal components, most notably E-selectin, for propagation and outgrowth.1 The paper provides further scientific support for the clinical trial in breast cancer patients with bone metastasis that was recently announced by GlycoMimetics.

innovation-lightbulb-pixa

The Golden State is living up to its nickname, with California ranking as the most innovative economy in America.

That’s according to Bloomberg’s newest U.S. State Innovation Index based on six equally-weighted metrics: research and development intensity, productivity, clusters of companies in technology, “STEM” jobs, populous with degrees in science and engineering disciplines, and patent activity.

healthcare-heart-beat-pixa

It has four chambers, blood vessels and it beats — sort of.

In a first, scientists have 3D printed a heart using human tissue. Though the heart is much smaller than a human's (it's only the size of a rabbit's), and there's still a long way to go until it functions like a normal heart, the proof-of-concept experiment could eventually lead to personalized organs or tissues that could be used in the human body, according to a study published Monday (April 15) in the journal Advanced Science.

viela-bio-logo

Viela Bio today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for the Company’s anti-CD19 monoclonal antibody inebilizumab, an investigational monotherapy for neuromyelitis optica spectrum disorder (NMOSD). NMOSD is a rare, life-threatening autoimmune disease affecting the central nervous system.

washington-view-3-pixa

If asked “What’s the most talent competitive city in the U.S.?” few Americans would name the top of our global list: Washington, D.C. (1). Often considered to be a (political) quagmire, the greater metropolitan area actually has a tremendous amount to offer. With an excellent environmental quality, major universities, an impressive number of physicians in the area and, of course, the presence of international global organisations, the greater Washington area provides a complete environment for talent competitiveness.

us-hhs-gov-logo

A nascent project launched by the Health and Human Services Department aims to spur innovation and help solve an expensive health crisis plaguing millions of Americans: kidney disease.

Developers hope it will one day be used as a model not only for introducing innovators to government, but for addressing other high-cost diseases.

biobuzz-5-stem-cell-0419-logo

The BioHealth Capital Region (BHCR) is rapidly becoming an industry hub for companies that are developing next-generation therapeutics that focus on personalized and regenerative medicine for the treatment and potential cure of unmet medical needs. Autolus, Inc., a CAR T-cell therapy company, and REGENXBIO, a gene therapy company focused therapies for rare diseases, are two examples of emerging leaders in the personalized medicine field making their imprint on the region.

disease-heart-health-pixa

Scientists at Tel Aviv University (TAU) have printed the world’s first 3D vascularized engineered heart using a patient’s own cells and biological materials. Their findings appear (“Printing of Personalized Thick and Perfusable Cardiac Patches and Hearts”) in Advanced Science.